"Agreement on Joint Research Agreement on Artificial Intelligence (AI)-based Medical Big Data Utilization Technology." <(From the left) Kim Kyung-nam, CEO of Waycen Inc., Song Young-gu, head of the hospital at Gangnam Severance Hospital, Lee Do-heon, head of the KAIST Gene Consent Guarantee Project Group>
[Medical Newspaper, Daily Life Insurance = Reporter Lee Sang-man]
Yonsei University Gangnam Severance Hospital (Hospital Director Song Young-gu) signed a "Joint Research Agreement on Artificial Intelligence (AI)-based medical big data utilization technology" with KAIST Genetic Agreement (Director Lee Do-heon) and Waycen (CEO Kim Kyung-nam).
The signing ceremony held at Gangnam Severance Hospital in the morning of the 9th was attended by officials from the agreement-related organizations, including general manager Lee Do-hun, CEO Kim Kyung-nam, and hospital director Song Young-gu, and all participants strictly followed quarantine guidelines.
The three organizations that participated in the business agreement decided to join forces for the expansion of various medical fields by developing next-generation diagnosis, prediction methods and new therapeutic materials using medical big data.
Reporter Lee Sang-man email@example.com
<All rights reserved @Medical Newspaper>